Key ongoing issues in trial design

Mark G. Jones, Luca Richeldi

Source: Eur Respir Monogr 2016; 71: 253-259
Disease area: Interstitial lung diseases

Full text journal articleCongress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mark G. Jones, Luca Richeldi. Key ongoing issues in trial design. Eur Respir Monogr 2016; 71: 253-259

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical trials during the COVID-19 pandemic: research design and lessons
Source: Eur Respir Monogr 2021; 94: 214-231
Year: 2021


Web-based collaborative training of clinical reasoning: a randomized trial
Source: Annual Congress 2009 - E-learning in medical education
Year: 2009


New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Clinical case discussion: How clinical trials inform antibiotic stewardship
Source: ERS webinar 2022: Clinical case discussion: How clinical trials inform antibiotic stewardship
Year: 2022


Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


Common pitfalls in planning and conducting epidemiological and clinical research
Source: Annual Congress 2008 - PG10 - Getting it right – planning, realising, analysing and publishing research projects
Year: 2008



Thoracic oncology, this journal club will explore a major randomised trial in mesothelioma treatment, implications for practice and the strengths and weaknesses of the study in the context of the published data
Source: Journal Club 2022
Year: 2022

Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

Study design: features of non-experimental studies
Source: Eur Respir Monogr 2014; 65: 249-256
Year: 2014


Patient perspective of participation in COVID-19 clinical trials
Source: Virtual Congress 2021 – Innovations in nurse-led interventions in respiratory diseases
Year: 2021


Was the implementation strategy of the ProACT trial adequately proactive?
Source: Breathe, 15 (1) 77; 10.1183/20734735.0338-2018
Year: 2019



Educational information events to enhance recruitment to clinical research trials
Source: International Congress 2015 – New developments in medical education, web and internet
Year: 2015


A smart mHealth tool versus a paper action plan to support self-management of COPD exacerbations: a randomised controlled trial
Source: International Congress 2019 – M-health/e-health I
Year: 2019

Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009


Delivery room management: current evidence from multi-centre trials: Support trial
Source: Research Seminar 2010 - Managing the lung of the extremely low gestational age neonate (ELGAN) in the delivery room
Year: 2010